Navidea biopharmaceuticals strengthens board of directors with the appointment of malcolm witter

Dublin, ohio--(business wire)--navidea biopharmaceuticals, inc. (nyse american: navb) (“navidea” or the “company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the appointment malcolm g. witter to its board of directors. mr. witter brings decades of financial and corporate governance experience to the board. he currently serves as a corporate development leader for usi insurance services (“usi”) and is responsible for acquiri
NAVB Ratings Summary
NAVB Quant Ranking